Latest Schedule 13D activist filings

A group of reporting persons, including Windsor Private Capital LP and Jordan Kupinsky, have reduced their beneficial ownership in Firefly Neuroscience, Inc. below the 5% threshold, triggering an exit filing.

A group of activist investors, including Endeavor Blockchain, LLC, has increased its beneficial ownership in Mawson Infrastructure Group Inc. to 48.0%, signaling potential strategic changes.

Saba Capital Management, L.P. and affiliates have reduced their beneficial ownership in AllianceBernstein National Municipal Income Fund, Inc. to 6.61% through recent open market sales.

Bluescape Energy Partners and affiliated entities reaffirm their significant 16.8% beneficial ownership in Riley Exploration Permian through an updated Schedule 13D filing.

BVF Partners and affiliated entities report ceasing beneficial ownership of Repare Therapeutics Inc. shares following its acquisition by XenoTherapeutics.

Icahn Enterprises affiliates have provided written consent to the merger and certificate of incorporation amendment for Enzon Pharmaceuticals, Inc.

Katmandu Ventures and Jill K. Markey reduced their beneficial ownership in Falcon's Beyond Global, Inc. through recent stock dispositions.

Hunt Equity Opportunities, LLC has acquired a controlling 92.2% stake in Kelly Services' Class B Common Stock, signaling intent for significant governance and strategic influence.

A group of activist investors, including Chain of Lakes Investment Fund, LLC, Haluk L. Bayraktar, and Emre Aciksoz, have significantly reduced their beneficial ownership in Lantronix Inc. to 5.73% through recent open market sales.

Paulson & Co. Inc. increased its beneficial ownership in International Tower Hill Mines Ltd. to 38.1% through recent share acquisitions totaling approximately $25 million.

BW Group Limited has reduced its beneficial ownership in DHT Holdings, Inc. to 9.49% after selling 1.6 million shares in January 2026.

Groupe Bruxelles Lambert updated its Schedule 13D filing for Concentrix Corporation, reflecting a 14.24% beneficial ownership stake and outlining investor rights.

Taiwan Carbon Nano Technology Corporation (TCNT) has reduced its stake in Ainos, Inc. to 13.62% and entered a voting agreement granting Ainos KY sole discretion over its voting shares.

Ainos Inc. (Cayman Islands) filed Amendment 14 to its Schedule 13D, updating its beneficial ownership in Ainos, Inc. (Texas) to 6.76% and disclosing a minor share sale by TCNT.

Key reporting persons, including AE Red Holdings and Michael Robert Greene, have reduced their beneficial ownership in Redwire Corp through recent open market share sales.

The Terence E. Adderley Revocable Trust K completed the sale of its entire 3,039,940 Class B Common Stock stake in Kelly Services Inc. for $106 million, with a potential earn-out.

1Globe Capital LLC, 1Globe Biomedical (Hong Kong) Company Limited, and Dr. Jiaqiang Li have increased their beneficial ownership in Sinovac Biotech Ltd. to 32.3% while actively engaged in multiple ongoing legal disputes concerning corporate control and share validity.

SAIF Partners IV L.P. and YZ Healthcare L.P. have amended and restated their investment agreement concerning the sale of Sinovac Biotech Ltd. common shares, extending key option periods and clarifying terms.

Tactic Pharma LLC and its principals have ceased to be beneficial owners of more than five percent of Monopar Therapeutics common stock following a pro rata distribution to its members.

A Schedule 13D/A filing reveals a significant dilution of beneficial ownership for Kevin Xiaofeng Ma and affiliated entities in ATA Creativity Global following a recent ADS issuance.

Jun Zhang and Arts Consulting Limited report a reduced beneficial ownership stake in ATA Creativity Global following the issuer's recent issuance of new shares.

Elwood G. Norris and related entities have significantly reduced their stake in WRAP Technologies, selling over 800,000 shares and filing intent to sell an additional 1.7 million shares.

Daewoong Co., Ltd. and Daewoong Pharmaceutical Co., Ltd. have increased their beneficial ownership in AEON Biopharma, Inc. to 49.99% through an exchange of convertible notes for common stock, a new note, and warrants.

Daewoong Co., Ltd. and Daewoong Pharmaceutical Co. Ltd. report their beneficial ownership in AEON Biopharma, Inc. has fallen below 1% due to recent dilution and a reverse stock split.

David E. Lazar has filed an exit amendment for his Schedule 13D, reporting a 4.99% beneficial ownership in NovaBay Pharmaceuticals, Inc. following the conversion of preferred stock.

CASI Pharmaceuticals, Inc. has secured a $5 million convertible promissory note from ETP Global III Fund LP, marking the first tranche of a $20 million financing initiative.

Khosla Ventures and Vinod Khosla have increased their beneficial ownership in LanzaTech Global, Inc. to 64.2% following preferred stock conversion and warrant issuance.

Carl Icahn and affiliated entities have reduced their beneficial ownership in Southwest Gas Holdings, Inc. to 4.99%, ceasing to be a greater than 5% shareholder.

CDP Investissements Inc. and Caisse de depot et placement du Quebec filed an amendment to their Schedule 13D, reaffirming a 20.1% beneficial ownership in Zevia PBC.

A group of entities and individuals associated with Mario Gabelli increased their beneficial ownership in Monro, Inc. to 7.23% of outstanding common stock.